HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone

• Michelle Bronze ,

  * E-mail: michelle.bronze@gmail.com

  Affiliation Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Kim Steegen,

  Affiliation Virco BVBA, Beerse, Belgium

  ⨯
• Carole L. Wallis,

  Affiliation Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Hans De Wolf,

  Affiliation Virco BVBA, Beerse, Belgium

  ⨯
• Maria A. Papathanasopoulos,

  Affiliation Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Margriet Van Houtte,

  Affiliation Virco BVBA, Beerse, Belgium

  ⨯
• Wendy S. Stevens,

  Affiliation Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Tobias Rinke de Wit,

  Affiliation Center for Poverty-related Communicable Diseases (CPCD), PharmAccess Foundation, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Lieven J. Stuyver,

  Affiliation Virco BVBA, Beerse, Belgium

  ⨯
• on behalf of the ART-A Consortium

  ¶Membership of the ART-A Consortium is provided in the Acknowledgments.

  ⨯